旭富 (4119)
旭富 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$163.39M, up 33.1% from a year earlier. EPS over the last four quarters totals NT$0.50.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2004-01-07
- Founded
- 1987-09-18
- Paid-in capital
- NT$1.20B
- Common shares issued
- 119,508,634
- Legal name
- 旭富製藥科技股份有限公司
- Website
- https://www.sci-pharmtech.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$163.39M | +9.7% | +33.1% |
| 2026-08 | NT$148.95M | -21.9% | +187.5% |
Year to date: +16.6% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.11 |
| 2026 Q1 | 0.17 |
| 2025 Q4 | 0.33 |
| 2025 Q3 | 0.11 |
| 2025 Q2 | 0.19 |
| 2025 Q1 | 0.27 |
| 2024 Q4 | 0.39 |
| 2024 Q3 | 3.19 |
Last four quarters: NT$0.50
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.75 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 18,687 | 0.7% |
| 1,000–5,000 shares | 5,663 | 10.1% |
| 5,001–10,000 shares | 1,075 | 6.6% |
| 10,001–15,000 shares | 365 | 3.8% |
| 15,001–20,000 shares | 184 | 2.7% |
| 20,001–30,000 shares | 211 | 4.4% |
| 30,001–40,000 shares | 86 | 2.5% |
| 40,001–50,000 shares | 67 | 2.6% |
| 50,001–100,000 shares | 114 | 6.6% |
| 100,001–200,000 shares | 49 | 5.6% |
| 200,001–400,000 shares | 29 | 6.7% |
| 400,001–600,000 shares | 2 | 0.8% |
| 600,001–800,000 shares | 3 | 1.8% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 9 | 45.0% |
TDCC data for 2026-10-16: 9 holders own more than 1,000 lots (45.0% of shares), and 18,687 hold less than one lot (0.7%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 122 | 0 | 1 | 123 |
| 2026-10-16 | 2 | 0 | 0 | 2 |
| 2026-10-15 | -24 | 0 | 8 | -16 |
| 2026-10-14 | 10 | 0 | 0 | 10 |
| 2026-10-13 | -2 | 0 | 0 | -2 |
| 2026-10-12 | 15 | 0 | 1 | 16 |
| 2026-10-08 | 18 | 0 | 0 | 18 |
| 2026-10-07 | 45 | 0 | 0 | 45 |
| 2026-10-06 | 36 | 0 | 0 | 36 |
| 2026-10-05 | -34 | 0 | 0 | -34 |
| 2026-10-02 | 1 | 0 | 2 | 3 |
| 2026-10-01 | -2 | 0 | 0 | -2 |
| 2026-09-30 | 30 | 0 | 1 | 31 |
| 2026-09-29 | -20 | 0 | -1 | -21 |
| 2026-09-24 | -49 | 0 | 0 | -49 |
| 2026-09-23 | -3 | 0 | 0 | -3 |
| 2026-09-22 | 15 | 0 | 0 | 15 |
| 2026-09-21 | -16 | 0 | 1 | -15 |
| 2026-09-18 | -14 | 0 | 6 | -8 |
| 2026-09-17 | 15 | 0 | 1 | 16 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 165 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$52.40 (2026-10-19); 52-week range NT$39.60–60.70.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.